Sensei Biotherapeutics Statistics
Total Valuation
SNSE has a market cap or net worth of $38.37 million. The enterprise value is -$14.07 million.
| Market Cap | 38.37M |
| Enterprise Value | -14.07M |
Important Dates
The last earnings date was Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SNSE has 25.08 million shares outstanding. The number of shares has decreased by -18.85% in one year.
| Shares Outstanding | 25.08M |
| Shares Change (YoY) | -18.85% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 34.49% |
| Owned by Institutions (%) | 9.25% |
| Float | 16.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.66 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.07, with a Debt / Equity ratio of 0.10.
| Current Ratio | 12.07 |
| Quick Ratio | n/a |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -244.51 |
Financial Efficiency
Return on equity (ROE) is -46.70% and return on invested capital (ROIC) is -54.26%.
| Return on Equity (ROE) | -46.70% |
| Return on Assets (ROA) | -40.90% |
| Return on Capital (ROIC) | -54.26% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.14M |
| Employee Count | 28 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.00% in the last 52 weeks. The beta is 0.14, so SNSE's price volatility has been lower than the market average.
| Beta (1Y) | 0.14 |
| 52-Week Price Change | +2.00% |
| 50-Day Moving Average | 1.18 |
| 200-Day Moving Average | 0.89 |
| Relative Strength Index (RSI) | 58.43 |
| Average Volume (30 Days) | 191,064 |
Short Selling Information
The latest short interest is 60,131, so 0.24% of the outstanding shares have been sold short.
| Short Interest | 60,131 |
| Short Previous Month | 81,034 |
| Short % of Shares Out | 0.24% |
| Short % of Float | 0.37% |
| Short Ratio (days to cover) | 0.69 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -34.79M |
| Pretax Income | -31.92M |
| Net Income | -31.92M |
| EBITDA | -29.05M |
| EBIT | -31.79M |
| Earnings Per Share (EPS) | -$1.21 |
Balance Sheet
The company has $58.08 million in cash and $5.64 million in debt, giving a net cash position of $52.44 million or $2.09 per share.
| Cash & Cash Equivalents | 58.08M |
| Total Debt | 5.64M |
| Net Cash | 52.44M |
| Net Cash Per Share | $2.09 |
| Equity / Book Value | 58.47M |
| Book Value Per Share | 2.33 |
| Working Capital | 55.24M |
Cash Flow
In the last 12 months, operating cash flow was -$27.90 million and capital expenditures $91,000, giving a free cash flow of -$27.81 million.
| Operating Cash Flow | -27.90M |
| Capital Expenditures | 91,000 |
| Free Cash Flow | -27.81M |
| FCF Per Share | -$1.11 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SNSE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 18.85% |
| Shareholder Yield | 18.85% |
| Earnings Yield | -83.17% |
| FCF Yield | -72.48% |
Analyst Forecast
The average price target for SNSE is $4.50, which is 194.12% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.50 |
| Price Target Difference | 194.12% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |